---
title: "CapsoVision, Inc. (CV.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CV.US.md"
symbol: "CV.US"
name: "CapsoVision, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T10:12:24.712Z"
locales:
  - [en](https://longbridge.com/en/quote/CV.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CV.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CV.US.md)
---

# CapsoVision, Inc. (CV.US)

## Company Overview

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [capsovision.com](https://capsovision.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: B (0.30)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 32 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 12.61% |  |
| Net Profit YoY | -28.00% |  |
| P/B Ratio | 16.19 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 327441356.19 |  |
| Revenue | 13563000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 47.12% | A |
| Profit Margin | -198.87% | E |
| Gross Margin | 47.60% | B |
| Revenue YoY | 12.61% | B |
| Net Profit YoY | -28.00% | D |
| Total Assets YoY | 108.43% | A |
| Net Assets YoY | 126.53% | A |
| Cash Flow Margin | 88.77% | C |
| OCF YoY | 12.61% | B |
| Turnover | 0.71 | B |
| Gearing Ratio | 22.07% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - CapsoVision, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "12.61%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-28.00%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "16.19",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "327441356.19",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "13563000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "47.12%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-198.87%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "47.60%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "12.61%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-28.00%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "108.43%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "126.53%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "88.77%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "12.61%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.71",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "22.07%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -12.14 | 151/183 | - | - | - |
| PB | 16.19 | 137/183 | 26.53 | 15.74 | 12.08 |
| PS (TTM) | 24.14 | 128/183 | 24.64 | 18.58 | 16.86 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 6.57 |
| Highest Target | 10.00 |
| Lowest Target | 10.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CV.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CV.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CV.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CV.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**